Viewing Study NCT06022861


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-27 @ 9:54 PM
Study NCT ID: NCT06022861
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2023-08-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sponsor: Shandong Boan Biotechnology Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module